275 related articles for article (PubMed ID: 15728438)
1. Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram.
Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
J Psychopharmacol; 2005 Mar; 19(2):166-72. PubMed ID: 15728438
[TBL] [Abstract][Full Text] [Related]
2. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study.
Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
J Clin Psychopharmacol; 2003 Dec; 23(6):563-7. PubMed ID: 14624186
[TBL] [Abstract][Full Text] [Related]
3. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
[TBL] [Abstract][Full Text] [Related]
4. SLC6A4 variation and citalopram response.
Mrazek DA; Rush AJ; Biernacka JM; O'Kane DJ; Cunningham JM; Wieben ED; Schaid DJ; Drews MS; Courson VL; Snyder KA; Black JL; Weinshilboum RM
Am J Med Genet B Neuropsychiatr Genet; 2009 Apr; 150B(3):341-51. PubMed ID: 18618621
[TBL] [Abstract][Full Text] [Related]
5. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
[TBL] [Abstract][Full Text] [Related]
6. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
[TBL] [Abstract][Full Text] [Related]
7. The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder.
Durham LK; Webb SM; Milos PM; Clary CM; Seymour AB
Psychopharmacology (Berl); 2004 Aug; 174(4):525-9. PubMed ID: 12955294
[TBL] [Abstract][Full Text] [Related]
8. Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.
Choi MJ; Kang RH; Ham BJ; Jeong HY; Lee MS
Neuropsychobiology; 2005; 52(3):155-62. PubMed ID: 16127283
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure.
Ahmed AT; Biernacka JM; Jenkins G; Rush AJ; Shinozaki G; Veldic M; Kung S; Bobo WV; Hall-Flavin DK; Weinshilboum RM; Wang L; Frye MA
J Affect Disord; 2019 Mar; 246():62-68. PubMed ID: 30578947
[TBL] [Abstract][Full Text] [Related]
10. HTR1A/1B DNA methylation may predict escitalopram treatment response in depressed Chinese Han patients.
Wang P; Lv Q; Mao Y; Zhang C; Bao C; Sun H; Chen H; Yi Z; Cai W; Fang Y
J Affect Disord; 2018 Mar; 228():222-228. PubMed ID: 29275155
[TBL] [Abstract][Full Text] [Related]
11. The combined effects of the 5-HTTLPR and 5-HTR1A genes modulates the relationship between negative life events and major depressive disorder in a Chinese population.
Zhang K; Xu Q; Xu Y; Yang H; Luo J; Sun Y; Sun N; Wang S; Shen Y
J Affect Disord; 2009 Apr; 114(1-3):224-31. PubMed ID: 18848359
[TBL] [Abstract][Full Text] [Related]
12. Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes.
Mitjans M; Gastó C; Catalán R; Fañanás L; Arias B
J Psychopharmacol; 2012 Oct; 26(10):1391-8. PubMed ID: 22826533
[TBL] [Abstract][Full Text] [Related]
13. 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.
Illi A; Setälä-Soikkeli E; Viikki M; Poutanen O; Huhtala H; Mononen N; Lehtimäki T; Leinonen E; Kampman O
Neuroreport; 2009 Aug; 20(12):1125-8. PubMed ID: 19590397
[TBL] [Abstract][Full Text] [Related]
14. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
[TBL] [Abstract][Full Text] [Related]
15. Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders.
Yu YW; Tsai SJ; Liou YJ; Hong CJ; Chen TJ
Eur Neuropsychopharmacol; 2006 Oct; 16(7):498-503. PubMed ID: 16458487
[TBL] [Abstract][Full Text] [Related]
16. The effects of the dopamine and serotonin transporter polymorphisms on clinical features and treatment response in geriatric depression: a pilot study.
Lavretsky H; Siddarth P; Kumar A; Reynolds CF
Int J Geriatr Psychiatry; 2008 Jan; 23(1):55-9. PubMed ID: 17621383
[TBL] [Abstract][Full Text] [Related]
17. Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.
Arias B; Serretti A; Lorenzi C; Gastó C; Catalán R; Fañanás L
J Affect Disord; 2006 Feb; 90(2-3):251-6. PubMed ID: 16356553
[TBL] [Abstract][Full Text] [Related]
18. TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression.
Arias B; Fabbri C; Gressier F; Serretti A; Mitjans M; Gastó C; Catalán R; De Ronchi D; Fañanás L
Neuropsychobiology; 2013; 67(1):41-7. PubMed ID: 23221997
[TBL] [Abstract][Full Text] [Related]
19. Association between functional polymorphisms in serotonin transporter gene (SLC6A4) and escitalopram treatment response in depressive patients in a South Indian population.
Mandal T; Bairy LK; Sharma PSVN
Eur J Clin Pharmacol; 2020 Jun; 76(6):807-814. PubMed ID: 32253447
[TBL] [Abstract][Full Text] [Related]
20. Association of serotonin transporter (SLC6A4) and receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study.
Basu A; Chadda RK; Sood M; Kaur H; Kukreti R
Indian J Med Res; 2015 Jul; 142(1):40-5. PubMed ID: 26261165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]